Efficacy of SGLT2 inhibitors on bone mineral density in patients with type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000016921
- Lead Sponsor
- Akishima Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Complicated severe nephropathy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone mineral density compared to that of a young adult mean
- Secondary Outcome Measures
Name Time Method Hemoglobin A1c level, body mass index, renal function parameters in blood and urine and serum lipid profiles